News

Article

Prevent Blindness launches fourth annual Thyroid Eye Disease Week

The week focuses on bringing awareness to TED through emphasis on mental health and art therapy solutions.

(Image Credit: AdobeStock/Chanintorn.v)

(Image Credit: AdobeStock/Chanintorn.v)

Prevent Blindness has declared the week of November 13-19 as the fourth annual Thyroid Eye Disease (TED) Awareness Week.1

Also known as Grave’s Disease, TED is an autoimmune disease in which the immune system causes inflammation and swelling and also stimulates the production of muscle tissue and fat behind the eye. The increased amounts of tissue, muscles and fat behind the eye cause the eyes to bulge outward.

In some cases, the eye may be pushed forward enough causing the eyelids to not close properly while sleeping or blinking. While in severe cases it could lead to vision loss.

A previous study showed that those who suffer from TED are more likely to suffer from depression and anxiety, which highlights the psychosocial impact of TED and associated socioeconomic risk factors.2

Due to this, Prevent Blindness will debut a new episode in the Focus on Eye Health Expert Series titled, “Thyroid Eye Disease and Mental Wellness.” In the episode, Prem Subramanian, MD, PhD, Clifford R and Janice N Merrill Endowed Chair in Ophthalmology and Vice Chair for Academic Affairs at Sue Anschutz-Rodgers Eye Center, UCHealth, discusses the potential impact on mental health, and the importance of patient and healthcare provider communication to help improve health outcomes.1

“Now in our 4th consecutive year, we are proud to continue to educate the public and provide patients and care partners with support for Thyroid Eye Disease,” said Jeff Todd, Prevent Blindness president and CEO. “Our goal is to provide comprehensive TED resources to empower patients, and encourage them to discuss their diagnosis, as well as any changes in mental health, to help limit the impact that TED may have on their health and quality of life.”

Prevent Blindness also offers TED patients and care partners the Prevent Blindness Art Therapy Program, designed to build community and connections among those affected by TED and provide the opportunity to create art using a variety of artistic media to express thoughts and feelings.

References:
  1. Prevent Blindness provides free educational materials on Thyroid Eye Disease, including new Focus on Eye Health Export series episode, and debuts online art gallery from participants in the Prevent Blindness Art Therapy program. Accessed November 13, 2023. https://preventblindness.org/2023-thyroid-eye-disease-week/
  2. Lee TC, Radha-Saseendrakumar B, Delavar A, Ye GY, Ting MA, Topilow NJ, Bass J, Korn BS, Kikkawa DO, Baxter SL, Liu CY. Evaluation of Depression and Anxiety in a Diverse Population With Thyroid Eye Disease Using the Nationwide NIH All of Us Database. Ophthalmic Plast Reconstr Surg. 2023 May-Jun 01;39(3):281-287. doi: 10.1097/IOP.0000000000002318. Epub 2023 Jan 24. Erratum in: Ophthalmic Plast Reconstr Surg. 2023 May-Jun 01;39(3):305. PMID: 36727790.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.